These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36096976)

  • 21. Lirentelimab for severe and chronic forms of allergic conjunctivitis.
    Anesi SD; Tauber J; Nguyen QD; Chang P; Berdy GJ; Lin CC; Chu DS; Levine HT; Fernandez AD; Roy N; Asbell PA; Kantor AM; Chang AT; Singh B; Youngblood BA; Jeng BH; Jhanji V; Rasmussen HS; Foster CS
    J Allergy Clin Immunol; 2022 Sep; 150(3):631-639. PubMed ID: 35390403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital.
    Sruthi V; Reddy RN; Sowmini K; Grace NS
    Indian J Pharmacol; 2020; 52(6):476-481. PubMed ID: 33666188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.
    Ali A; Bielory L; Dotchin S; Hamel P; Strube YNJ; Koo EB
    Surv Ophthalmol; 2024; 69(2):265-278. PubMed ID: 37890678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical grading of vernal keratoconjunctivitis.
    Bonini S; Sacchetti M; Mantelli F; Lambiase A
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):436-41. PubMed ID: 17873585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ocular allergies].
    Messmer EM
    Ophthalmologe; 2005 May; 102(5):527-43; quiz 544. PubMed ID: 15806370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of a new therapy using rebamipide eyedrops in patients with VKC/AKC refractory to conventional anti-allergic treatments.
    Ueta M; Sotozono C; Koga A; Yokoi N; Kinoshita S
    Allergol Int; 2014 Mar; 63(1):75-81. PubMed ID: 24457813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Topical Cyclosporine 0.05% the Treatment of Vernal Keratoconjunctivitis.
    Subedi K; Sharma B; Shrestha S
    Nepal J Ophthalmol; 2020 Jan; 12(23):39-47. PubMed ID: 32799238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
    Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M
    Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Allergic conjunctivitis in children].
    Zepeda Ortega B; Rosas Vargas MA; Ito Tsuchiya FM; del Río Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2007; 54(2):41-53. PubMed ID: 17542245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of corticosteroid eye drops for allergic eye diseases in children].
    Csorba A; Soproni A; Maneschg O; Nagy ZZ; Szamosi A
    Orv Hetil; 2019 Mar; 160(9):329-337. PubMed ID: 30798620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis.
    Trocme SD; Kephart GM; Allansmith MR; Bourne WM; Gleich GJ
    Am J Ophthalmol; 1989 Jul; 108(1):57-63. PubMed ID: 2750834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.
    Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J
    Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyposensitization in the treatment of resistant cases of vernal keratoconjunctivitis.
    Mahdy RA; Nada WM; Shahien EA; Boghdadi GA; Marei AA
    Cutan Ocul Toxicol; 2010 Sep; 29(3):198-202. PubMed ID: 20670088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
    Leonardi A; Borghesan F; Faggian D; Depaoli M; Secchi AG; Plebani M
    Am J Ophthalmol; 2000 Feb; 129(2):151-8. PubMed ID: 10682966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of allergic conjunctivitis].
    Hidasi V
    Orv Hetil; 2000 Aug; 141(34):1859-65. PubMed ID: 11006710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysbiosis of Ocular Surface Microbiota in Patients With Refractive Allergic Conjunctival Diseases.
    Inada N; Shoji J; Harata G; Miyazawa K; He F; Tomioka A; Hirota A; Tonozuka Y; Yamagami S
    Cornea; 2022 Oct; 41(10):1232-1241. PubMed ID: 34879043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allergic and immunopathological diseases of the ocular surface].
    Módis L; Süveges I
    Orv Hetil; 2023 Oct; 164(43):1686-1692. PubMed ID: 37898906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.